Skip to main content
Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
13.50
-0.11 (-0.81%)
Apr 29, 2026, 10:08 AM EDT - Market open

Viridian Therapeutics Revenue

In the year 2025, Viridian Therapeutics had annual revenue of $70.85M with 23,359.93% growth. Viridian Therapeutics had revenue of $132.00K in the quarter ending December 31, 2025, with 83.33% growth.

Revenue (ttm)
$70.85M
Revenue Growth
+23,359.93%
P/S Ratio
19.80
Revenue / Employee
$281,147
Employees
252
Market Cap
1.39B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202570.85M70.55M23,359.93%
Dec 31, 2024302.00K-12.00K-3.82%
Dec 31, 2023314.00K-1.46M-82.28%
Dec 31, 20221.77M-1.19M-40.20%
Dec 31, 20212.96M1.91M182.19%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ardelyx 407.32M
Immunocore Holdings 400.02M
Iovance Biotherapeutics 263.50M
Wave Life Sciences 71.80M
Agios Pharmaceuticals 54.03M
Precigen 9.68M
Maze Therapeutics 2.50M
Revenue Rankings

VRDN News

More News